Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors

BACKGROUND: Activating mutations in Kit receptor tyrosine kinase or the related platelet-derived growth factor receptor (PDGFR) play an important role in the pathogenesis of gastrointestinal stromal tumors (GIST). METHODS: This study investigated the activity of motesanib, an inhibitor of vascular e...

Descripción completa

Detalles Bibliográficos
Autores principales: Caenepeel, Sean, Renshaw-Gegg, Lisa, Baher, Angelo, Bush, Tammy L, Baron, Will, Juan, Todd, Manoukian, Raffi, Tasker, Andrew S, Polverino, Anthony, Hughes, Paul E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912835/
https://www.ncbi.nlm.nih.gov/pubmed/20633291
http://dx.doi.org/10.1186/1756-9966-29-96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912835/
https://www.ncbi.nlm.nih.gov/pubmed/20633291
http://dx.doi.org/10.1186/1756-9966-29-96

Ejemplares similares